MVA85A vaccine

Recombinant Modified Vaccinia Ankara expressing antigen 85A · University of Oxford

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MVA85A vaccine, covering 2007-01-29 to 2013-07-02. Get the full timeline:

Most recent: Clinical Trial Update: Safety of Tuberculosis Vaccine, MVA85A, Administered by the Aerosol Route and the Intradermal Route [Phase 1]